Science Links Japan | The Efficacy of Tumor-dormancy Therapy Using an Angiogenesis Inhibitor and Differentiation Agents for Dogs with Skeletal or Extraskeletal Osteosarcoma

The Efficacy of Tumor-dormancy Therapy Using an Angiogenesis Inhibitor and Differentiation Agents for Dogs with Skeletal or Extraskeletal Osteosarcoma

Accession number;04A0468024

Title;The Efficacy of Tumor-dormancy Therapy Using an Angiogenesis Inhibitor and Differentiation Agents for Dogs with Skeletal or Extraskeletal Osteosarcoma

Author; OSAKI TOMOHIRO (Hokkaido Univ., Fac. of Vet. Med.) KADOSAWA TSUYOSHI (Hokkaido Univ., Fac. of Vet. Med.) MATSUMOTO YASUHIRO (Hokkaido Univ., Fac. of Vet. Med.) TAKAGI SATOSHI (Hokkaido Univ., Fac. of Vet. Med.) OKUMURA MASAHIRO (Hokkaido Univ., Fac. of Vet. Med.) FUJINAGA TOORU (Hokkaido Univ., Fac. of Vet. Med.)

Journal Title;Journal of the Japan Veterinary Medical Association

Journal Code:Y0220A

ISSN:0446-6454

VOL.57;NO.6;PAGE.386-390(2004)

Figure&Table&Reference;FIG.4, TBL.2, REF.18

Pub. Country;Japan

Language;Japanese

Abstract;Tumor-dormancy therapy using an angiogenesis inhibitor and two differentiation agents as clinical trials was employed to treat two dogs with skeletal or extraskeletal osteosarcoma, respectively. Because, in both cases, QOL was well maintained and tumor progression was slow, the tumor-dormancy therapy seems effective as a treatment for dogs with osteosarcoma. (author abst.)

Related Articles;